logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
L

Lin Wu

Central South University
H指数:22
被引数:1,916

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study

Vebreltinib治疗MET扩增驱动型晚期非小细胞肺癌（KUNPENG研究）：一项单臂、多队列、多中心、Ⅱ期研究

The Lancet Oncology
IF0
2025-12-060
PRE
Yi-Long Wu; Yu Yao; Jin-Ji Yang; Lin Wu; Wei Zhang; Ying Wang; Hai-Peng Xu; Yong Song; Yan Zhang; Jun Zhao; Jing-Hua Chen; Zhe-Hai Wang; Qi-Ming Wang; Jie Hu; Xing-Ya Li; Yun Fan; Yuan Chen; Jian Fang; Di Han; Wei-Zhe Xue
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial

Ivonescimab 联合化疗与 tislelizumab 联合化疗作为晚期鳞状非小细胞肺癌的一线治疗（HARMONi-6）：一项随机、双盲、Ⅲ期临床试验

The Lancet
IF97.3
2025-10-190
PRE
Zhiwei Chen; Fang Yang; Zhou Jiang; Longhua Sun; Lin Wu; Zhengxiang Han; Yun Fan; Yanqiu Zhao; Xingya Li; Haipeng Xu; Xiangjiao Meng; Ying Liu; Zhiye Zhang; Hui Luo; Xuelei Ma; Xuezhen Ma; Qin Shi; Zhongmin Zhang; Runxiang Yang; Pingli Wang; Pinhua Pan; Xiaohong Ai; Jie Li; Xingxiang Pu; Zhiwu Wang; Jian Fang; Ming He; Yong He; Shuliang Guo; Juan Li; Hongbiao Wang; Junqiang Zhang; Qian Chu; Xuewen Liu; Shenpeng Ying; Hongcheng Wu; Hongmei Sun; Yinghua Ji; Ming Zhou; Chao Cao; Kejing Tang; Zhengguo Li; Dairong Li; Zhihong Zhang; Jie Li; Jianya Zhou; Hongzhong Yang; Yingying Du; Hui Yang; Jian Shi; Hualin Chen; Wenting Li; Dongmei Lu; Mingxiu Hu; Zhongmin Maxwell Wang; Baiyong Li; Michelle Xia; Shun Lu
Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial

利美ertenib相较于吉非替尼，作为携带EGFR敏感突变局部晚期或转移性非小细胞肺癌的一线治疗的疗效与安全性：一项随机、双盲、双模拟、III期临床试验

The Lancet Respiratory Medicine
IF0
2025-06-200
PRE
Yuankai Shi; Lin Wu; Yinghua Ji; Gongyan Chen; Baolan Li; Minghong Bi; Runxiang Yang; Liyun Miao; Guojun Zhang; Hongjun Gao; Longhua Sun; Mingjun Zhang; Shundong Cang; Meili Sun; Wenxiu Yao; Zhijie Pan; Jiuwei Cui; Yi Xiao; Qiming Wang
Final analysis of camrelizumab plus chemotherapy for untreated advanced or metastatic esophageal squamous cell carcinoma: The ESCORT-1st trial

camrelizumab联合化疗治疗未经治疗的晚期或转移性食管鳞状细胞癌的最终分析: ESCORT-1st试验

MED
IF11.8
2024-09-011
PRE
He, Mingming; Wang, Zhiqiang; Lu, Jin; Bai, Yuxian; Mao, Teng; Wang, Jun; Fan, Qingxia; Zhang, Yiping; Zhao, Kuaile; Chen, Zhendong; Gao, Shegan; Li, Jiancheng; Fu, Zhichao; Gu, Kangsheng; Liu, Zhihua; Wu, Lin; Zhang, Xiaodong; Feng, Jifeng; Niu, Zuoxing; Ba, Yi; Zhang, Helong; Liu, Ying; Zhang, Li; Min, Xuhong; Huang, Jing; Cheng, Ying; Wang, Dong; Sheng, Zhen; Zeng, Wanqin; Song, Li; Xu, Rui-Hua; Luo, Huiyan
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2024-08-050
OAAI
Zhong, Qiaofeng; Zhang, Longfeng; Wu, Lin; Zhao, Jun; Sun, Jianguo; Fang, Yong; Zhou, Jin; Chu, Qian; Shen, Yihong; Yang, Zhenzhou; Chen, Lijin; Huang, Meijuan; Lin, Xiaoyan; Liu, Zhenhua; Shen, Peng; Wang, Zhijie; Wang, Xin; Wang, Huijuan; Han, Chengbo; Liu, Anwen; Zhang, Hongmei; Ye, Feng; Gao, Wen; Wu, Fang; Song, Zhengbo; Chen, Shengchi; Zhou, Chengzhi; Huang, Dingzhi; Zhang, Qiuyu; Zheng, Xinlong; Zheng, Xiaobin; Miao, Qian; Jiang, Kan; Zou, Zihua; Xu, Yiquan; Wu, Shiwen; Wang, Haibo; Hong, Yaping; Lu, Tao; Li, Chao; Huang, Cheng; Chen, Chuanben; Lin, Gen
Efficacy and safety of Low dose radiotherapy (LDRT) concurrent Atezolizumab (Atezo) plus chemotherapy as first line (1L) therapy for ES-SCLC: Primary analysis of Phase II MATCH study
CANCER RESEARCH
IF16.6
2023-04-141
PRE
Zhou, Lin; Sun, Jianguo; Xie, Conghua; Gong, Youling; Huang, Meijuan; Yuan, Zhiyong; Wu, Lin; Wang, Hui; Bi, Nan; Xu, Yaping; Zhu, Jiang; Liu, Yongmei; Zhang, Yan; Fan, Min; Zou, Bingwen; Yu, Min; Li, Yanying; Na, Feifei; Xiu, Weigang; Xu, Yong; Wang, Jin; Zhang, Xuanwei; Xue, Jianxin; Lu, You

研究方向

暂未获取到该数据
S
Siqi Liu
H 指数:54论文数:491被引数:2.3万
K
Kaisong Xiang
H 指数:19论文数:67被引数:1,159
X
Xiaomin Lou
H 指数:23论文数:142被引数:3,900
刘
刘辉
H 指数:80论文数:1,162被引数:2.8万
林亮 封面图
林亮
H 指数:48论文数:239被引数:1.3万
G
Guozhen Liu
H 指数:80论文数:501被引数:2.3万
Y
Yingxue Fu
H 指数:5论文数:14被引数:180
H
Heng Zhu
H 指数:70论文数:261被引数:2.2万
J
Jun Wu
H 指数:37论文数:160被引数:4,351
H
Hao Chen
H 指数:15论文数:42被引数:798